Nasdaq · CIK 0001111485
RXST RxSight, Inc.
Insider trading from SEC Form 4. Last filing 26 d ago. Close $4.81 on Oct 9, 2026, +5% from the 52-week low and -63% from the high.
Last 90 days
Net insider value
-$118k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
4
$118k by 4 insiders
Insiders on file
14
with a Form 4 at this company
Price and insider trades, last year
RXSTOct 9, 2026 · close 4.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at RxSight, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Ilya Goldshleger Chief Operating Officer sell | $14k 2,041 shares | -2% | +53% from low-46% from high | |
| 21Weak | Ronald M Kurtz MD Chief Medical Officer sell | $35k 5,100 shares | -7% | +53% from low-46% from high | |
| 15Weak | Eric Weinberg See remarks sell | $14k 2,041 shares | -1% | +53% from low-46% from high | |
| 34Weak | Mark Wilterding Chief Financial Officer sell | $54k 7,765 shares | -24% | +53% from low-46% from high | |
| 12Weak | Tamara Fountain director sell | $180k 7,000 shares | -22% | - | |
| 38Weak | Jesse Anderson Corley director buy | $100k 3,210 shares | - | - | |
| 0Weak | Ilya Goldshleger See remarks sell | $143k 3,105 shares | -7% | - | |
| 7Weak | Ilya Goldshleger See remarks sell | $282k 6,200 shares | -14% | - | |
| 24Weak | Shweta Maniar director sell | $174k 3,782 shares | -26% | - | |
| 8Weak | Ilya Goldshleger See remarks sell | $364k 7,975 shares | -17% | - | |
| 40Moderate | Jesse Anderson Corley director buy | $1.0M 22,476 shares | +5% | - | |
| 0Weak | Ilya Goldshleger See remarks sell | $61k 1,330 shares | -3% | - | |
| 0Weak | Ilya Goldshleger See remarks sell | $170k 3,100 shares | -7% | - | |
| 0Weak | Ilya Goldshleger See remarks sell | $158k 3,100 shares | -7% | - | |
| 0Weak | Ilya Goldshleger See remarks sell | $161k 3,105 shares | -7% | - | |
| 0Weak | Ilya Goldshleger See remarks sell | $311k 6,200 shares | -14% | - | |
| 0Weak | Ilya Goldshleger See remarks sell | $154k 3,100 shares | -7% | - | |
| 0Weak | Ilya Goldshleger See remarks sell | $310k 6,205 shares | -14% | - | |
| 2Weak | Ilya Goldshleger See remarks sell | $462k 9,305 shares | -21% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Eric Weinberg See remarks | MOption exercise Common Stock | +35,168 | $4.34 | $153k | 235,516 | 26 d ago |
| Sep 15, 2026 | Eric Weinberg See remarks | MOption exercise Stock Option (right to buy)derivative | -35,168 | $0.00 | $0 | 0 | 26 d ago |
| Sep 5, 2026 | Ilya Goldshleger Chief Operating Officer | DDisposition to issuer Stock option (right to buy)derivative | -98,367 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Mark Wilterding Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -258,770 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Eric Weinberg See remarks | DDisposition to issuer Stock option (right to buy)derivative | -87,437 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Ronald M Kurtz MD Chief Medical Officer | DDisposition to issuer Stock option (right to buy)derivative | -338,819 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Ilya Goldshleger Chief Operating Officer | DDisposition to issuer Stock Option (right to buy)derivative | -120,000 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Mark Wilterding Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +258,770 | - | - | 258,770 | 33 d ago |
| Sep 5, 2026 | Eric Weinberg See remarks | DDisposition to issuer Stock Option (right to buy)derivative | -95,000 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Ronald M Kurtz MD Chief Medical Officer | DDisposition to issuer Stock Option (right to buy)derivative | -200,000 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Eric Weinberg See remarks | DDisposition to issuer Stock Option (right to buy)derivative | -92,200 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Ilya Goldshleger Chief Operating Officer | DDisposition to issuer Stock Option (right to buy)derivative | -92,200 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Ronald M Kurtz MD Chief Medical Officer | DDisposition to issuer Stock Option (right to buy)derivative | -149,000 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Ilya Goldshleger Chief Operating Officer | DDisposition to issuer Stock Option (right to buy)derivative | -50,000 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Ronald M Kurtz MD Chief Medical Officer | DDisposition to issuer Stock Option (right to buy)derivative | -215,000 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Eric Weinberg See remarks | DDisposition to issuer Stock Option (right to buy)derivative | -50,000 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Ronald M Kurtz MD Chief Medical Officer | AGrant or award Stock Option (right to buy)derivative | +254,751 | - | - | 254,751 | 33 d ago |
| Sep 5, 2026 | Eric Weinberg See remarks | DDisposition to issuer Stock Option (right to buy)derivative | -125,000 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Ilya Goldshleger Chief Operating Officer | DDisposition to issuer Stock Option (right to buy)derivative | -125,000 | - | - | 0 | 33 d ago |
| Sep 5, 2026 | Ronald M Kurtz MD Chief Medical Officer | AGrant or award Stock Option (right to buy)derivative | +173,913 | - | - | 173,913 | 33 d ago |
| Sep 5, 2026 | Eric Weinberg See remarks | AGrant or award Stock Option (right to buy)derivative | +65,742 | - | - | 65,742 | 33 d ago |
| Sep 5, 2026 | Ilya Goldshleger Chief Operating Officer | AGrant or award Stock Option (right to buy)derivative | +73,960 | - | - | 73,960 | 33 d ago |
| Sep 5, 2026 | Ronald M Kurtz MD Chief Medical Officer | AGrant or award Stock Option (right to buy)derivative | +96,129 | - | - | 96,129 | 33 d ago |
| Sep 5, 2026 | Ilya Goldshleger Chief Operating Officer | AGrant or award Stock Option (right to buy)derivative | +104,347 | - | - | 104,347 | 33 d ago |
| Sep 5, 2026 | Eric Weinberg See remarks | AGrant or award Stock Option (right to buy)derivative | +82,608 | - | - | 82,608 | 33 d ago |
| Sep 5, 2026 | Ronald M Kurtz MD Chief Medical Officer | AGrant or award Stock Option (right to buy)derivative | +161,654 | - | - | 161,654 | 33 d ago |
| Sep 5, 2026 | Ilya Goldshleger Chief Operating Officer | AGrant or award Stock Option (right to buy)derivative | +59,483 | - | - | 59,483 | 33 d ago |
| Sep 5, 2026 | Eric Weinberg See remarks | AGrant or award Stock Option (right to buy)derivative | +59,483 | - | - | 59,483 | 33 d ago |
| Sep 5, 2026 | Ilya Goldshleger Chief Operating Officer | AGrant or award Stock Option (right to buy)derivative | +32,258 | - | - | 32,258 | 33 d ago |
| Sep 5, 2026 | Eric Weinberg See remarks | AGrant or award Stock Option (right to buy)derivative | +32,258 | - | - | 32,258 | 33 d ago |
| Sep 5, 2026 | Ilya Goldshleger Chief Operating Officer | AGrant or award Stock Option (right to buy)derivative | +93,984 | - | - | 93,984 | 33 d ago |
| Sep 5, 2026 | Eric Weinberg See remarks | AGrant or award Stock Option (right to buy)derivative | +93,984 | - | - | 93,984 | 33 d ago |
| Aug 31, 2026 | Ilya Goldshleger Chief Operating Officer | MOption exercise Common Stock | +5,370 | - | - | 83,550 | 40 d ago |
| Aug 31, 2026 | Ronald M Kurtz MD Chief Medical Officer | MOption exercise Common Stock | +13,425 | - | - | 76,875 | 40 d ago |
| Aug 31, 2026 | Eric Weinberg See remarks | MOption exercise Common Stock | +5,370 | - | - | 202,389 | 40 d ago |
| Aug 31, 2026 | Mark Wilterding Chief Financial Officer | MOption exercise Common Stock | +20,441 | - | - | 32,814 | 40 d ago |
| Sep 2, 2026 | Ilya Goldshleger Chief Operating Officer | SOpen-market sale Common Stock | -2,041 | $6.96 | $14k | 81,509 | 40 d ago |
| Sep 2, 2026 | Ronald M Kurtz MD Chief Medical Officer | SOpen-market sale Common Stock | -5,100 | $6.96 | $35k | 71,775 | 40 d ago |
| Sep 2, 2026 | Eric Weinberg See remarks | SOpen-market sale Common Stock | -2,041 | $6.96 | $14k | 200,348 | 40 d ago |
| Sep 2, 2026 | Mark Wilterding Chief Financial Officer | SOpen-market sale Common Stock | -7,765 | $6.96 | $54k | 25,049 | 40 d ago |
| Aug 31, 2026 | Mark Wilterding Chief Financial Officer | MOption exercise Restricted Stock Unitderivative | -20,441 | $0.00 | $0 | 122,646 | 40 d ago |
| Aug 31, 2026 | Ilya Goldshleger Chief Operating Officer | MOption exercise Restricted Stock Unitderivative | -5,370 | $0.00 | $0 | 26,848 | 40 d ago |
| Aug 31, 2026 | Ronald M Kurtz MD Chief Medical Officer | MOption exercise Restricted Stock Unitderivative | -13,425 | $0.00 | $0 | 67,120 | 40 d ago |
| Aug 31, 2026 | Eric Weinberg See remarks | MOption exercise Restricted Stock Unitderivative | -5,370 | $0.00 | $0 | 26,848 | 40 d ago |
| Jul 31, 2025 | Raymond W Cohen director | AGrant or award Common Stock | +35,668 | $0.00 | $0 | 35,668 | Aug 4, 2025 |
| Jun 3, 2025 | Julie Andrews director | AGrant or award Common Stock | +10,752 | - | - | 41,039 | Jun 4, 2025 |
| Jun 3, 2025 | Jesse Anderson Corley director | AGrant or award Common Stock | +10,752 | - | - | 49,190 | Jun 4, 2025 |
| Jun 3, 2025 | Tamara Fountain director | AGrant or award Common Stock | +10,752 | - | - | 35,545 | Jun 4, 2025 |
| Jun 3, 2025 | William J Link Phd director | AGrant or award Common Stock | +10,752 | - | - | 37,855 | Jun 4, 2025 |
| Jun 3, 2025 | Shweta Maniar director | AGrant or award Common Stock | +10,752 | - | - | 18,135 | Jun 4, 2025 |
| Jun 3, 2025 | Robert J Palmisano director | AGrant or award Common Stock | +10,752 | - | - | 41,039 | Jun 4, 2025 |
| Jun 3, 2025 | Bakker Juliet Tammenoms director | AGrant or award Common Stock | +10,752 | - | - | 48,146 | Jun 4, 2025 |
| Jun 3, 2025 | Robert Keith Warner director | AGrant or award Common Stock | +10,752 | - | - | 41,039 | Jun 4, 2025 |
| Jun 2, 2025 | Eric Weinberg See remarks | MOption exercise Common Stock | +188,002 | $3.93 | $739k | 195,351 | Jun 3, 2025 |
| Jun 2, 2025 | Eric Weinberg See remarks | MOption exercise Stock Option (right to buy)derivative | -188,002 | $0.00 | $0 | 0 | Jun 3, 2025 |
| Apr 14, 2025 | Shelley B Thunen See remarks | MOption exercise Common Stock | +7,792 | $4.34 | $34k | 38,354 | Apr 15, 2025 |
| Apr 14, 2025 | Shelley B Thunen See remarks | MOption exercise Stock Option (right to buy)derivative | -6,405 | $0.00 | $0 | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Shelley B Thunen See remarks | MOption exercise Stock Option (right to buy)derivative | -1,387 | $0.00 | $0 | 0 | Apr 15, 2025 |
| Mar 12, 2025 | Tamara Fountain director | SOpen-market sale Common Stock10b5-1 | -7,000 | $25.71 | $180k | 24,793 | Mar 13, 2025 |
| Feb 27, 2025 | Ilya Goldshleger See remarks | AGrant or award Stock Option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Feb 27, 2025 |
| Feb 27, 2025 | Ronald M Kurtz MD President & CEO | AGrant or award Stock Option (right to buy)derivative | +215,000 | $0.00 | $0 | 215,000 | Feb 27, 2025 |
| Jan 15, 2025 | Jesse Anderson Corley director | POpen-market purchase Common Stockindirect: By spouse | +1,443 | $31.19 | $45k | 1,443 | Jan 17, 2025 |
| Jan 16, 2025 | Jesse Anderson Corley director | POpen-market purchase Common Stockindirect: By spouse | +1,767 | $31.13 | $55k | 3,210 | Jan 17, 2025 |
| Nov 29, 2024 | Ilya Goldshleger See remarks | MOption exercise Common Stock10b5-1 | +3,105 | $15.08 | $47k | 45,351 | Dec 3, 2024 |
| Nov 29, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -3,105 | $46.08 | $143k | 42,246 | Dec 3, 2024 |
| Nov 29, 2024 | Ilya Goldshleger See remarks | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,105 | $0.00 | $0 | 40,777 | Dec 3, 2024 |
| Nov 26, 2024 | Shweta Maniar director | SOpen-market sale Common Stock10b5-1 | -3,782 | $45.88 | $174k | 10,902 | Nov 26, 2024 |
| Nov 22, 2024 | Ilya Goldshleger See remarks | MOption exercise Common Stock10b5-1 | +3,100 | $15.08 | $47k | 45,346 | Nov 26, 2024 |
| Nov 22, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -3,100 | $45.00 | $140k | 42,246 | Nov 26, 2024 |
| Nov 26, 2024 | Ilya Goldshleger See remarks | MOption exercise Common Stock10b5-1 | +3,100 | $15.08 | $47k | 45,346 | Nov 26, 2024 |
| Nov 26, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -3,100 | $45.88 | $142k | 42,246 | Nov 26, 2024 |
| Nov 22, 2024 | Ilya Goldshleger See remarks | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,100 | $0.00 | $0 | 46,982 | Nov 26, 2024 |
| Nov 26, 2024 | Ilya Goldshleger See remarks | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,100 | $0.00 | $0 | 43,882 | Nov 26, 2024 |
| Nov 15, 2024 | Ilya Goldshleger See remarks | MOption exercise Common Stock10b5-1 | +4,875 | $15.08 | $74k | 47,121 | Nov 18, 2024 |
| Nov 15, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -4,875 | $46.00 | $224k | 42,246 | Nov 18, 2024 |
| Nov 18, 2024 | Ilya Goldshleger See remarks | MOption exercise Common Stock10b5-1 | +3,100 | $15.08 | $47k | 45,346 | Nov 18, 2024 |
| Nov 18, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -3,067 | $45.00 | $138k | 42,279 | Nov 18, 2024 |
| Nov 18, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -33 | $45.07 | $1,487 | 42,246 | Nov 18, 2024 |
| Nov 15, 2024 | Ilya Goldshleger See remarks | MOption exercise Stock Option (right to buy)derivative10b5-1 | -4,875 | $0.00 | $0 | 53,182 | Nov 18, 2024 |
| Nov 18, 2024 | Ilya Goldshleger See remarks | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,100 | $0.00 | $0 | 50,082 | Nov 18, 2024 |
| Nov 12, 2024 | Jesse Anderson Corley director | POpen-market purchase Common Stockindirect: See footnote | +11,111 | $45.37 | $504k | 468,571 | Nov 14, 2024 |
| Nov 12, 2024 | Ilya Goldshleger See remarks | MOption exercise Common Stock10b5-1 | +1,330 | $15.08 | $20k | 43,576 | Nov 14, 2024 |
| Nov 13, 2024 | Jesse Anderson Corley director | POpen-market purchase Common Stockindirect: See footnote | +5,570 | $45.00 | $251k | 474,141 | Nov 14, 2024 |
| Nov 12, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -1,330 | $46.13 | $61k | 42,246 | Nov 14, 2024 |
| Nov 13, 2024 | Jesse Anderson Corley director | POpen-market purchase Common Stock | +4,090 | $44.98 | $184k | 36,733 | Nov 14, 2024 |
| Nov 13, 2024 | Jesse Anderson Corley director | POpen-market purchase Common Stock | +1,705 | $44.50 | $76k | 38,438 | Nov 14, 2024 |
| Nov 12, 2024 | Ilya Goldshleger See remarks | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,330 | $0.00 | $0 | 58,057 | Nov 14, 2024 |
| Nov 7, 2024 | Ilya Goldshleger See remarks | MOption exercise Common Stock10b5-1 | +3,100 | $15.08 | $47k | 45,346 | Nov 8, 2024 |
| Nov 7, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -2,900 | $54.96 | $159k | 42,446 | Nov 8, 2024 |
| Nov 7, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -200 | $55.53 | $11k | 42,246 | Nov 8, 2024 |
| Nov 7, 2024 | Ilya Goldshleger See remarks | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,100 | $0.00 | $0 | 59,387 | Nov 8, 2024 |
| Nov 4, 2024 | Ilya Goldshleger See remarks | MOption exercise Common Stock10b5-1 | +3,100 | $15.08 | $47k | 45,346 | Nov 5, 2024 |
| Nov 4, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -2,840 | $50.98 | $145k | 42,506 | Nov 5, 2024 |
| Nov 4, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -260 | $51.74 | $13k | 42,246 | Nov 5, 2024 |
| Nov 4, 2024 | Ilya Goldshleger See remarks | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,100 | $0.00 | $0 | 62,487 | Nov 5, 2024 |
| Oct 30, 2024 | Ilya Goldshleger See remarks | MOption exercise Common Stock10b5-1 | +3,105 | $15.08 | $47k | 45,351 | Oct 31, 2024 |
| Oct 30, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -3,105 | $51.91 | $161k | 42,246 | Oct 31, 2024 |
| Oct 30, 2024 | Ilya Goldshleger See remarks | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,105 | $0.00 | $0 | 65,587 | Oct 31, 2024 |
| Oct 25, 2024 | Ilya Goldshleger See remarks | MOption exercise Common Stock10b5-1 | +3,100 | $15.08 | $47k | 45,346 | Oct 28, 2024 |
| Oct 25, 2024 | Ilya Goldshleger See remarks | SOpen-market sale Common Stock10b5-1 | -3,100 | $49.79 | $154k | 42,246 | Oct 28, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Julie Andrewscfo, officer, director
- Raymond W Cohenceo, officer, director
- Jesse Anderson Corleydirector
- Tamara Fountaindirector
- Ilya GoldshlegerChief Operating Officer
- Ronald M Kurtz MDChief Medical Officer
- William J Link Phddirector
- Shweta Maniardirector
- Robert J Palmisanodirector
- Bakker Juliet Tammenomsdirector
- Shelley B ThunenSee remarks
- Robert Keith Warnerdirector
- Eric WeinbergSee remarks
- Mark WilterdingChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.